Frank R. Jimenez

Frank R. Jimenez (board member) discloses dealings in 4 companies, chiefly Huntington Ingalls Industries, Inc., GE HealthCare Technologies Inc. and Raytheon Co/. The record holds 57 filings, for trades running from 20 January 2016 to 1 October 2026.

In open-market terms, that means 3 purchases worth €280k on one side and 1 sale worth €98k on the other. Purchases outweigh sales by €181k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 53 share grants. 2026 to date brings 1 purchase and no sales.

The median purchase comes to €94k. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 67% of cases, with a median move of +0.0%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 2 October 2026: a share grant of €43k, in Huntington Ingalls Industries, Inc. The most recent open-market purchase was published on 30 April 2026, 171 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.